Harmonic Pharma DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

FDA Approves First Gene Therapy for Rare Immune Disorder

10 Dec 2025

// REUTERS

US FDA Approves First Drug Under New Fast-Track Review Program

10 Dec 2025

// REUTERS

Pfizer Partners with Yao Pharma to Develop Weight Management Drug

10 Dec 2025

// BUSINESSWIRE

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

Cell Bio

Not Confirmed

Book a meeting

envelop Contact Supplier

Latest Content

radio-compass-blog/dmf-filings-rise-4-5-in-q3-2025-china-holds-lead-india-records-20-growth-in-submissions

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

About

Harmonic Pharma has been founded in 2009 with a core technology dedicated to drug repurposing. The company has developed a platform to investigate the mechanism of action of any type of chemicals over the last years. Complementary AI-based solutions have been developed through the dual program entitled Chemical Range to provide public and private organizations with a more comprehensive toxicity profiling. December 2017, Seqens group announced his support to Harmonic Pharma through a capital increase. According to Pierre Luzeau, President of Seqens : “The access to Harmonic Pharma’s technology broadens Seqens’ services.